10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 364 filers reported holding 10X GENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.41 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $790,322 | +44.1% | 14,183 | -5.8% | 0.00% | -50.0% |
| Q4 2022 | $548,385 | +26.9% | 15,052 | -0.9% | 0.00% | -20.0% |
| Q3 2022 | $432,000 | -43.2% | 15,185 | -9.7% | 0.01% | -37.5% |
| Q2 2022 | $761,000 | -39.3% | 16,821 | +2.1% | 0.01% | -57.9% |
| Q1 2022 | $1,254,000 | +323.6% | 16,483 | +727.5% | 0.02% | +280.0% |
| Q4 2021 | $296,000 | +29.3% | 1,992 | +26.4% | 0.01% | 0.0% |
| Q3 2021 | $229,000 | -19.4% | 1,576 | +8.8% | 0.01% | -16.7% |
| Q2 2021 | $284,000 | +25.7% | 1,449 | +16.2% | 0.01% | +20.0% |
| Q1 2021 | $226,000 | – | 1,247 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 8,185,565 | $952,538,000 | 99.56% |
| Foresite Capital Management I, LLC | 2,750,000 | $342,870,000 | 96.54% |
| Foresite Capital Management II, LLC | 3,503,528 | $436,820,000 | 95.05% |
| 12 West Capital Management LP | 1,922,000 | $239,635,000 | 11.66% |
| FINANCIAL CONSULATE, INC | 163,366 | $20,368,000 | 9.67% |
| JS Capital Management LLC | 606,400 | $75,606,000 | 3.91% |
| Asymmetry Capital Management, L.P. | 43,512 | $5,425,000 | 3.49% |
| Pinz Capital Management, LP | 55,400 | $6,907,000 | 2.52% |
| HAMILTON LANE ADVISORS LLC | 37,087 | $4,624,000 | 2.24% |
| RTW INVESTMENTS, LP | 660,933 | $82,405,000 | 1.98% |